CI

At a glance

ClinicalIndex Comparison Record
Phase 2Active· 74 enrolled
Drug / intervention
Intensity modulated radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00593840
NCT00593840Phase 2Active
CompareCT.gov

Phase II Trial Evaluating Elimination of Radiation Therapy To Pathological N0 Neck(s) With Intensity Modulated Postoperative Radiation Therapy

Washington University School of Medicine·interventional·Posted Jan 15, 2008·Updated May 19, 2026

In Brief

A Phase 2 clinical trial evaluating Intensity modulated radiation therapy for Cancer of the Larynx. Active but no longer recruiting, targeting 74 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount of radiation treatment received to healthy tissue

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer of the Larynx
CountriesUnited States
Collaborators--

Timeline

Phase 2Active
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 15, 2008
Enrollment StartApr 11, 2007
Primary CompletionFeb 28, 2014
Study CompletionApr 30, 2027
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 18.5 years ago

Interventions

Intensity modulated radiation therapyradiation